Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion
Sponsor: Ain Shams University
Summary
The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.
Official title: Effect of Probiotics on Atrial Fibrillation Outcome in Patients Undergoing Cardioversion
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2026-05-10
Completion Date
2027-09-01
Last Updated
2026-05-06
Healthy Volunteers
No
Conditions
Interventions
Anticoagulant Therapy
Drug: The standard of care for AF management directly following cardioversion Include anticoagulant therapy for at least 4 weeks, rate control therapy, rhythm control therapy, or both as per clinical and guideline decisions.
Probiotics capsules
Probiotics at a of dose 25 billion / 1 capsule will be orally administered daily for 12 weeks
Locations (1)
Ain Shams University's Hospital
Cairo, Egypt